Ensysce Biosciences Secures Commercial Supplier For PF614-MPAR Overdose Protection Drug, Fully Establishing Supply Chain With GMP Nafamostat From Aurore Life Sciences

BenzingaDec 10 21:08

Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

BenzingaDec 6 21:55

Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending

BenzingaDec 6 08:50

Ensysce Biosciences To Carry Out 1-for-15 Reverse Stock Split On December 6th, 2024

December 4th (Eastern Time) - $Ensysce Biosciences(ENSC.US)$ is about to implement a 1-for-15 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from December 6th,

Futu NewsDec 5 09:35

Ensysce Biosciences Initiates PARtnership With A Drug Manufacturer For The Development And Commercial Launch Of PF614 And PF614-MPAR, Including A $10M Commitment From The Drug Manufacturer

BenzingaDec 4 21:17

Ensysce Biosciences Announces Strategic Partnership for the Development and Commercial Launch of PF614 and PF614-MPAR

AccesswireDec 4 21:00